“Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s717. https://doi.org/10.25251/kvstvq23.